Status:
RECRUITING
Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform
Lead Sponsor:
Cardenal Herrera University
Collaborating Sponsors:
Hospital de Manises
Universitat Politècnica de València
Conditions:
End Stage Renal Disease
Hemodialysis-Induced Symptom
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
There is wide evidence regarding the weak points of end-stage Chronic kidney disease (CKD) patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological ...
Detailed Description
CKD stage 5D, has a high incidence, 100-200 people per million, and high prevalence, 750-1500 per million. More than 40-50% are above 65 years old, with a lower rate in women but with higher frailty t...
Eligibility Criteria
Inclusion
- Patients on hemodialysis medically stable
- Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed
- Life expectancy greater than 6 months
Exclusion
- Myocardial infarction in the previous 6 weeks
- Angina unstable on exercise or at rest
- Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia.
- Life expectancy less than 6 months
- Cognitive impairment
- Language barriers
- Illiteracy
Key Trial Info
Start Date :
March 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04823286
Start Date
March 31 2021
End Date
August 31 2024
Last Update
February 16 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
KU Leuven
Leuven, Belgium, 3000
2
Aristotle University of Thessaloniki
Thessaloniki, Greece, 57001
3
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain
4
Hospital de Manises
Manises, Valencia, Spain, 46940